Roche receives CE Mark for blood test to identify tuberculosis infection
The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination...
Diagnostics
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Invited by the Stop TB Partnership and the Global Fund to participate as a manufacturer partnerWorkshop brings together national TB...
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
American Oncology Network (AON) and other community oncology providers launching now as part of a pilot program that provides access to...
Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on...
Home Sleep Apnea Testing Market to Reach USD 996.6 Million by 2036, Driven by Expanding Telehealth Adoption and Rising Demand for Portable Sleep Diagnostics
NEWARK, Del., July 8, 2026 /PRNewswire/ -- According to Future Market Insights (FMI), the global home sleep apnea testing market is projected...
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture WorkflowsNew heat-stable and hyperactive proteins across the fibroblast growth factor and...
Catalyst MedTech Announces Channel Partnership with APQ Health to Expand Access to Advanced Cardiac CT Analysis
PITTSBURGH, July 07, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced...
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology...
LANGAR INVESTMENT MANAGEMENT ANNOUNCES TRANSFER OF THE LANGAR GLOBAL HEALTHTECH ETF TO THE CBOE BZX EXCHANGE
LOS ANGELES, July 7, 2026 /PRNewswire/ -- Langar Investment Management LLC, the adviser to the Langar Global HealthTech ETF (NYSE...
Angel Aligner™ Launches iOrtho™ Release 6.2, Bringing Deeper Diagnostics, Smarter Prescriptions, and Faster Planning to Orthodontists Nationwide
Built from direct doctor feedback, iOrtho Release 6.2 launched July 1 with new improvements in CBCT visualization, new trimline flexibility...
ONTO Health Accelerates U.S. and International Expansion with Acquisition of LEVY Health
Strategic acquisition leverages LEVY Health's clinical decision support infrastructure to scale physician-led fertility and longevity care following $20 million Series...
New England Biolabs® launches the NEBNext® Companion Module for Oxford Nanopore Technologies® Direct RNA Sequencing
IPSWICH, Mass., July 7, 2026 /PRNewswire/ -- New England Biolabs (NEB®) has launched the NEBNext Companion Module for Oxford Nanopore...
VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
HENDERSON, Nev., July 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the...
Red Light Holland’s Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
John Chiminski, Former Catalent Chair and CEO, to Serve as CD&R Operating Advisor
NEW YORK, July 7, 2026 /PRNewswire/ -- CD&R (or the "Firm") today announced that John Chiminski, former Chair and Chief...
Beckman Coulter Diagnostics Expands Alzheimer’s Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay
CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of...
ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective response rate vs. everolimus Garching / Munich, July...
Levicept Appoints Darlene Deptula-Hicks as CFO
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for OsteoarthritisSANDWICH, United Kingdom,...
Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July...
In HelloNation, Dental Expert Dawn Strohschein, DDS, Explains How Modern Dental Technology Supports Oral and Airway Health
The article examines how advanced dental technologies improve diagnosis, treatment, and long-term wellness for patients.GILLETTE, Wyo., July 6, 2026 /PRNewswire/...